You are viewing an expired study
This study is not currently recruiting Study Participants on If you would like to find active studies please search for clinical trials

Cleveland, Ohio

  • Catheters, Indwelling


This trial is for patients with a central venous catheter (a vascular access device) that is not functioning properly (unable to withdraw blood). The trial compares a new blood clot dissolving agent (alfimeprase) against the currently used treatment.


Subjects must: - have a dysfunctional Central Venous Access Device (CVAD) defined as unable to withdraw 3 mL blood - have had the device in place for > 48 hours - be clinically stable - be 18 or older - give informed consent



Primary Contact:


Backup Contact:


Location Contact:

Cleveland, Ohio
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source:

Date Processed: April 07, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on The form below is not enabled.